Cambridge Investment Research Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-32,000	Closed	-$556K	–	2365
2018 Q4	$556K	Buy	+32,000	New	+$546K	0.01%	1253
2017 Q1	–	Sell	-10,843	Closed	-$192K	–	1826
2016 Q4	$192K	Sell	10,843 -393	-3%	-$6.9K	﹤0.01%	1514
2016 Q3	$217K	Buy	11,236 +1,215	+12%	+$23.8K	﹤0.01%	1505
2016 Q2	$195K	Buy	+10,021	New	+$197K	﹤0.01%	1385
2014 Q1	–	Sell	-8,234	Closed	-$218K	–	1353
2013 Q4	$218K	Buy	+8,234	New	+$202K	0.01%	1039

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Cambridge Investment Research Advisors's VIVO Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2019, closing a stake of 32,000 shares — an estimated $556K sold.

Cambridge Investment Research Advisors first reported a position in VIVO in Q4 2013 and held it in 5 quarters. The position peaked at $556K in Q4 2018. 183 funds tracked by Wall St. Rank hold VIVO as of Q1 2019.

Cambridge Investment Research Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2019 after selling out during the quarter.
Cambridge Investment Research Advisors sold 32,000 Meridian Bioscience Inc shares in Q1 2019, an estimated $556K.
Cambridge Investment Research Advisors first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 5 quarters.
Cambridge Investment Research Advisors's Meridian Bioscience Inc position peaked at $556K in Q4 2018.
183 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.